Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sugen's angiogenesis inhibitor SU-5416 enters phase I

Oct. 3, 1997

Favorable phase II/III data for Targretin in CTCL reported at dermatology congress

Oct. 2, 1997

Safety profile of VRCTC-310 established in rabbits

Oct. 2, 1997

Camptosar available in Canada

Oct. 1, 1997

Matrix announces restructuring to focus on oncology products

Oct. 1, 1997

Inex seeks Canadian approval to commence Onco TCS trials for lymphoma

Sep. 30, 1997

Taxotere efficacy demonstrated in NSCLC, gastric cancer

Sep. 29, 1997

Cancer gene therapy shows long-term benefits in mice

Sep. 29, 1997

New taxoids with improved anticancer activity

Sep. 26, 1997

Pierre Fabre develops novel anticancer carpaine derivatives

Sep. 26, 1997

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...